Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shot up 11.5% during mid-day trading on Tuesday . The stock traded as high as $0.25 and last traded at $0.25. 195 shares changed hands during trading, a decline of 65% from the average session volume of 560 shares. The stock had previously closed at $0.23.
Zelira Therapeutics Stock Performance
The firm’s 50-day moving average is $0.26 and its 200-day moving average is $0.27.
Zelira Therapeutics Company Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Recommended Stories
- Five stocks we like better than Zelira Therapeutics
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is It Time to Trim Your Positions in These 2 AI Stocks?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- These 3 Tech Stocks Just Supercharged Their Buybacks
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Dividend Stocks to Hold Through Market Volatility This Fall
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
